- Data on File. Geistlich Pharma AG, Wolhusen, Switzerland. (Non-clinical)
GEM 21S®, the first recombinant growth factor product for use in oral regenerative surgery. Learn More
GEM 21S®, the first recombinant growth factor product for use in oral regenerative surgery. Learn More